- From 1st September, Zostavax should be offered to individuals aged 70 years for the routine shingles immunisation programme and those aged 78 or 79 years for the catch-up programme.
- The antiemetic domperidone (Motilium) will now be available only as a POM.
- Malaria prevention advice for India and Sri Lanka has changed; prophylaxis is now recommended only for travel to the states of Assam and Orissa and certain districts of Andhra Pradesh and Madhya Pradesh in India and is no longer recommended for any area of Sri Lanka.
- Clinigen has launched a new glycopeptide antibacterial, telavancin (Vibativ), for treating nosocomial pneumonia known or suspected to be caused by MRSA.
- Stivarga (regorafenib) is now licensed for the treatment of unresectable or metastatic gastrointestinal stromal tumour that has progressed on imatinib and sunitinib, or where these agents are not tolerated.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.